Carisk Partners Launches Proprietary Pathways 2 Recovery™: Interdisciplinary, Patient-Centered Approach Improves Quality of Care in Catastrophic and Complex Workers’ Compensation Cases
Adial Pharmaceuticals Receives Notice of Allowance from US Patent and Trademark Office for Patent for the Treatment of Alcohol Use Disorder in Patients Identified Using a Molecular Genetic Biomarker
Sunshine Biopharma Initiates Adva-27a Xenograft Studies in Mice Carrying Different Types of Human Cancer
Experion Holdings Ltd Successfully Obtains DTC Eligibility for its Common Shares
Aytu BioScience Announces Positive Clinical Results from Natesto(R) Spermatogenesis Study
MIAMI–(BUSINESS WIRE)–#Pathways2Recovery–With the formal introduction of Pathways 2 Recovery™ (P2R), Carisk Partners (Carisk), a specialty…
CHARLOTTESVILLE, VA / ACCESSWIRE / October 17, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL)(NASDAQ:ADILW), a clinical-stage…
MONTREAL, QC / ACCESSWIRE / October 17, 2019 / Sunshine Biopharma, Inc. (OTC PINK:SBFM), a…
VANCOUVER, BC / ACCESSWIRE / October 17, 2019 / Experion Holdings Ltd. (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31), formerly Viridium…
Phase IV, Investigator-Initiated Study is First to Conclusively Show that a Testosterone Replacement Therapy (TRT)…
SAN CLEMENTE, CA / ACCESSWIRE / October 17, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer…
SAN DIEGO, CA and CALGARY, AB / ACCESSWIRE / October 17, 2019 / Oncolytics Biotech®…
South Pacific island group’s safety net healthcare system signs on for seven more years, plans…
CRV431 Decreased Liver Fibrosis and Tumor Burden in Experimental Models EDISON, NJ / ACCESSWIRE /…
MADISON, Wis.–(BUSINESS WIRE)–#EHR—Moxe’s release of information solution, Substrate, is now verified to interface with Epic’s…
